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ABSTRACT Mutations in the GJB2 gene (Cx26) cause deafness in humans. Most are loss-of-
function mutations and cause nonsyndromic deafness. Some mutations produce a gain of 
function and cause syndromic deafness associated with skin disorders, such as keratitis-ich-
thyosis-deafness syndrome (KIDS). Cx26-G45E is a lethal mutation linked to KIDS that forms 
constitutively active connexin hemichannels. The pathomechanism(s) by which mutant Cx26 
hemichannels perturb normal epidermal cornification are poorly understood. We created an 
animal model for KIDS by generating an inducible transgenic mouse expressing Cx26-G45E 
in keratinocytes. Cx26-G45E mice displayed reduced viability, hyperkeratosis, scaling, skin 
folds, and hair loss. Histopathology included hyperplasia, acanthosis, papillomatosis, in-
creased cell size, and osteal plugging. These abnormalities correlated with human KIDS pa-
thology and were associated with increased hemichannel currents in transgenic keratino-
cytes. These results confirm the pathogenic nature of the G45E mutation and provide a new 
model for studying the role of aberrant connexin hemichannels in epidermal differentiation 
and inherited connexin disorders.
INTRODUCTION
Connexins (Cx) were first identified as the subunit proteins of the 
intercellular membrane channels that cluster in the cell communica-
tion structures known as gap junctions (Revel and Karnovsky, 1967; 
Goodenough, 1974). Connexin proteins have been studied for 50 
years in the context of these intercellular channels and have been 
well characterized with regard to their role in mediating the direct 
exchange of ions, second messengers, metabolites, and short inter-
fering RNAs between adjacent coupled cells (Robertson, 1963; 
Kanno and Loewenstein, 1964; Lawrence et al., 1978; Bruzzone 
et al., 1996; Harris, 2001; Wei et al., 2004; Valiunas et al., 2005). 
More recently, connexins have been shown to also be capable of 
forming functional hemichannels in nonjunctional plasma mem-
branes that can enable the exchange of molecules between the cy-
tosol and the extracellular space, creating the possibility of addition-
ally influencing neighboring cells through paracrine signaling 
mechanisms (Bennett et al., 2003; Goodenough and Paul, 2003; 
Saez et al., 2003; Evans et al., 2006). The role played by connexin 
hemichannels in normal physiology is poorly understood (Scemes 
et al., 2009; Scemes, 2011), but there is accumulating evidence 
showing that their activity can be deleterious under certain patho-
logical conditions, including inherited disorders caused by connexin 
mutations (Lee and White, 2009; Schalper et al., 2009; Saez et al., 
2010; Levit et al., 2011).
Several human hereditary diseases, including hearing loss and 
skin disorders, have been linked to mutations in connexin genes 
(White and Paul, 1999; Richard, 2005; Lee and White, 2009). For 
example, mutations in GJB2 (Cx26) can cause both nonsyndromic 
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hearing loss and syndromic hearing loss associated with a variety of 
skin disorders, including palmoplantar keratoderma, Vohwinkel syn-
drome, Bart–Pumphrey syndrome, and keratitis–ichthyosis–deafness 
syndrome (KIDS; Richard et al., 1998, 2002, 2004; Maestrini et al., 
1999; van Steensel et al., 2002). Functional characterization of the 
disease-associated GJB2 mutations has alluded to different path-
omechanisms underlying nonsyndromic sensorineural hearing loss 
(SNHL) and syndromic hearing loss associated with skin disorders. 
Cx26 mutants causing nonsyndromic SNHL without skin manifesta-
tions have been shown to cause either a partial or total loss of gap 
junction function (White, 2000; Mese et al., 2007; Lee and White, 
2009). In contrast, mutations leading to syndromic SNHL and skin 
disorders were shown 1) to have impaired intracellular trafficking, 
leading to the accumulation of mutant connexin proteins within 
cells; 2) to inhibit transport and/or function of other coexpressed 
wild-type connexins (trans-dominant inhibition); and 3) to generate 
constitutively active connexin hemichannels. Thus mutant connexin 
proteins causing skin disease seem to acquire novel properties, re-
sulting in a gain-of-function effect (Rouan et al., 2001; Bakirtzis et al., 
2003; Bruzzone et al., 2003; Mese et al., 2004, 2008; Montgomery 
et al., 2004; Beltramello et al., 2005; Gerido et al., 2007; Lee et al., 
2009). In addition, a dramatic increase in Cx26 expression has been 
observed in human epidermis following pathological or experimen-
tally induced changes in keratinocyte proliferation and differentia-
tion, such as in response to retinoic acid treatment, in psoriatic 
skin lesions, in palmoplantar keratoderma, and in experimentally 
wounded skin (Masgrau-Peya et al., 1997; Rivas et al., 1997; 
Labarthe et al., 1998; Lucke et al., 1999; Rouan et al., 2001). Taken 
together, these studies establish a strong correlation between in-
creased Cx26 expression and increased keratinocyte proliferation 
and differentiation. In turn, the increased Cx26 expression would 
also amplify any pathological gain of function induced by Cx26 mu-
tations associated with skin disease, forming a positively reinforcing 
loop of mutation-driven disease.
Adult skin is composed of the mesodermally derived dermis and 
the ectodermally derived epidermis. The epidermis mainly contains 
keratinocytes forming four layers: the basal layer, the spinous layer, 
the granular layer, and the cornified layer. Cells in the basal layer 
continuously proliferate and terminally differentiate as they move 
upward into the spinous, granular, and cornified layers prior to be-
ing ultimately shed (Blanpain and Fuchs, 2006, 2009). Prior studies 
reported differential expression of several connexins in keratino-
cytes of the basal, spinous, and granular layers (Caputo and 
Peluchetti, 1977; Risek et al., 1992; Goliger and Paul, 1994). At least 
nine connexin genes, including Cx26, are expressed during kerati-
nocyte differentiation, and they show complex overlapping spatial 
and temporal expression patterns (Salomon et al., 1994; Di et al., 
2001; Richard, 2005; Mese et al., 2007). For the epidermis to func-
tion properly, basal keratinocytes must maintain a delicate balance 
between proliferation and differentiation mechanisms (Blanpain and 
Fuchs, 2009). Any perturbation of this balance can lead to skin ab-
normalities, like the hyperkeratotic skin disorders caused by domi-
nant gain-of-function mutations affecting Cx26 (Richard, 2000).
The most severe genetic disorder due to GJB2 (Cx26) mutations 
is the keratitis-ichthyosis-deafness syndrome. KIDS is an ectodermal 
dysplasia characterized by photophobia and vascularizing keratitis, 
SNHL or deafness, erythrokeratoderma, nail and hair abnormalities, 
and an increased prevalence of squamous cell carcinoma (Richard 
et al., 2002; van Steensel et al., 2002; van Steensel, 2004; 
Mazereeuw-Hautier et al., 2007). KIDS patients also have recur-
rent cutaneous infections that can lead to lethal septicemia in 
pediatric patients, particularly those carrying the Cx26-G45E 
mutation (Janecke et al., 2005; Griffith et al., 2006; Jonard et al., 
2008; Sbidian et al., 2010; Koppelhus et al., 2011). The phenotypic 
spectrum of KIDS is broad and may also include features of a follicu-
lar occlusion triad encompassing dissecting folliculitis, hidradenitis 
suppurativa, and cystic acne (Montgomery et al., 2004; Maintz et al., 
2005), mucositis (Brown et al., 2003; Lazic et al., 2008), or KIDS with 
proliferative pilar cysts (Nyquist et al., 2007). Current treatment of 
KIDS is symptomatic and aims to alleviate symptoms, and includes 
topical or systemic antibiotics/antifungals, keratolytics, and moistur-
izers (Richard, 2005; Abdollahi et al., 2007; Braun-Falco, 2009).
At least 10 different Cx26 mutations have been linked to KIDS 
in humans, and in vitro analysis demonstrated that the majority of 
these mutations lead to constitutively active hemichannels that 
significantly compromise cell viability and intracellular calcium ho-
meostasis (Montgomery et al., 2004; Stong et al., 2006; Gerido 
et al., 2007; Lee et al., 2009; Sanchez et al., 2010; Terrinoni et al., 
2010). Although the in vitro evidence generated thus far strongly 
suggests that hemichannel dysfunction significantly compromises 
cell homeostasis, the role of mutant Cx26 hemichannels in vivo 
during epidermal differentiation is still poorly understood. To bet-
ter characterize the mechanisms leading to KIDS in affected indi-
viduals and to evaluate the role of aberrant hemichannels in an 
animal model of this disorder, we generated an inducible trans-
genic mouse that expresses the Cx26-G45E KIDS mutation in basal 
keratinocytes.
RESULTS
Inducible expression of Cx26-G45E in epithelial cells 
leads to increased dye uptake
It was previously demonstrated that constitutive Cx26-G45E expres-
sion caused cell death linked to increased hemichannel activity in 
both Xenopus oocytes and mammalian cells (Stong et al., 2006; 
Gerido et al., 2007). To develop a doxycycline-inducible expression 
system, we subcloned wild-type Cx26 or Cx26-G45E into pTRE2, 
including an internal ribosome entry site (IRES) after the coding se-
quence, followed by the enhanced green fluorescent protein (EGFP), 
and cotransfected it into HeLa cells with the pTet-On plasmid. Expo-
sure of untransfected HeLa cells (Figure 1A) to doxycycline did not 
induce EGFP (Figure 1B) or Cx26-G45E (Figure 1C) protein expres-
sion. In contrast, cells cotransfected with pTRE2-Cx26-G45E-IRES-
EGFP and pTet-On (Figure 1D) produced a robust EGFP signal 
(Figure 1E) and expressed high levels of Cx26-G45E (Figure 1F) after 
24 h of incubation in doxycycline. To determine whether the ex-
pressed Cx26-G45E exhibited increased hemichannel activity, cells 
transfected with either wild-type Cx26 or Cx26-G45E were incu-
bated with neurobiotin tracer in the extracellular medium and 
washed, fixed, and stained with rhodamine-conjugated avidin. Wild-
type Cx26-expressing cells (Figure 1G) showed a strong EGFP signal 
(Figure 1H) but limited or no dye uptake (Figure 1I). Cells expressing 
Cx26-G45E (Figure 1J) displayed an equivalent EGFP signal (Figure 
1K) in conjunction with a greatly increased accumulation of cytoplas-
mic neurobiotin (Figure 1L). These data show that doxycycline-
inducible expression of Cx26-G45E resulted in increased dye uptake 
in transfected HeLa cells.
Expression of Cx26-G45E increases whole-cell 
membrane current
If the increased dye uptake seen in Cx26-G45E–expressing cells was 
mediated by the opening of connexin hemichannels, then one 
would predict that whole-cell membrane currents would also be 
greatly increased and that unitary channel conductance could be 
resolved. To test this hypothesis, we transfected N2A cells with 
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either wild-type Cx26 or Cx26-G45E and measured membrane 
currents and channel conductance by whole-cell patch clamp elec-
trophysiology (Figure 2). Untransfected N2A cells displayed minimal 
membrane currents when stepped to membrane potentials be-
tween −90 and +90 mV (Figure 2A). Membrane currents recorded 
from N2A cells transfected with wild-type Cx26 (Figure 2B) were not 
appreciably different from untransfected cells. However, Cx26-
G45E–expressing N2A cells exhibited much larger whole-cell mem-
brane currents at both hyperpolarizing and 
depolarizing potentials (Figure 2C). Plotting 
the current density as a function of mem-
brane potential (Figure 2D) showed that at 
all voltages tested, Cx26-G45E currents 
were at least twofold to threefold larger (p < 
0.01, analysis of variance [ANOVA]) than 
those recorded in either untransfected or 
wild-type Cx26 transfected cells. In some 
cells, the activity of single Cx26-G45E hemi-
channels could be resolved (Figure 2E). In 
this example, hemichannels had a unitary 
conductance value of ∼320 pS at a mem-
brane potential of −30 mV measured in 120 
mM K+ aspartate−. This value is in good 
agreement with recently reported human 
Cx26 hemichannel data (Sanchez et al., 
2010). Thus expression of Cx26-G45E re-
sulted in a significantly increased membrane 
current in transfected N2A cells mediated 
by connexin hemichannels.
Generation of inducible transgenic 
mice expressing Cx26-G45E in the 
epidermis
Using in vitro assays (Figures 1 and 2), we 
identified significant changes in the func-
tional behavior of the Cx26-G45E muta-
tion (Gerido et al., 2007; Sanchez et al., 
2010). To test whether the aberrant hemi-
channel properties of Cx26-G45E gener-
ate epidermal pathology in vivo in an ani-
mal model, we generated transgenic mice 
with an inducible expression of Cx26-G45E 
in basal keratinocytes of the epidermis un-
der the control of a tetracycline-responsive 
promoter (TRE-minCMV). The transgene 
contained the Cx26-G45E coding se-
quence, followed by an IRES and EGFP, 
producing a bicistronic mRNA encoding 
G45E and EGFP as independent proteins 
(Figure 3A). This TRE-G45E construct was 
injected into zygotic pronuclei, and posi-
tive founder mice were interbred with a 
second transgenic strain expressing the 
reverse tetracycline transactivator (rtTA) 
under the control of the keratin14 (K14) 
promoter (Nguyen et al., 2006) to produce 
doubly transgenic animals. Following in-
duction with doxycycline, K14-rtTA trans-
genic mice only produced rtTA transcripts 
in total epidermal RNA samples, whereas 
K14-rtTA plus TRE-G45E double-trans-
genic animals made both rtTA and G45E 
transcripts when assayed by reverse transcription (RT)-PCR (Fig-
ure 3, B–E). Transgenic animals were then backcrossed to the 
SKH1 hairless mouse strain (Benavides et al., 2009) to facilitate 
direct observation of the epidermis. As the multiple crosses re-
quired to generate these mice resulted in a mixed genetic back-
ground, K14-rtTA plus TRE-G45E double-transgenic animals were 
always compared with either TRE-G45E or K14-rtTA single-trans-
genic littermates as controls in all experiments. Examination of 
FIGuRE 1: Inducible expression of Cx26-G45E in HeLa cells increases dye uptake. 
Untransfected HeLa cells (A, blue DAPI stain) failed to express either EGFP (B, green) or Cx26 
(C, red) when treated with doxycycline. Cells cotransfected with pTRE2-Cx26-G45E-IRES-EGFP 
and pTet-On (D) showed a strong EGFP signal (E) and expressed high levels of Cx26-G45E 
(F) 24 h after doxycycline addition. To test for increased hemichannel activity, cells expressing 
either wild-type Cx26 or Cx26-G45E were incubated with neurobiotin tracer. Even though 
wild-type Cx26 expressing cells (G) showed a strong EGFP signal (H), they had very limited or no 
dye uptake from the extracellular medium (I, red). Cells expressing Cx26-G45E (J) displayed a 
similar EGFP signal as wild-type Cx26 expressing cells (K) but showed a dramatic increase in the 
accumulation of neurobiotin (L), consistent with an elevation of hemichannel activity due to the 
Cx26-G45E mutation. Scale bar, 5 μm.
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frozen sections of head epidermis by fluorescence microscopy 
showed an absence of EGFP and Cx26 in single K14-rtTA trans-
genic animals (Figure 4A). In contrast, K14-rtTA plus TRE-G45E 
double-transgenic mice showed a large induction of EGFP in kera-
tinocytes and a punctate pattern of Cx26-G45E staining (Figure 
4B). In vivo fluorescence detection of EGFP expression in whole 
animals after 2 wk of doxycycline induction showed that trans-
gene activity was induced throughout the epidermis (Figure 4, C 
and D). These data document that we generated a new trans-
genic model of KIDS in which we can detect the inducible expres-
sion of a transgenic bicistronic transcript and its protein products 
in the epidermis.
Cx26-G45E transgenic mice develop 
epidermal abnormalities
In patients with KIDS the epidermal differentiation process is 
severely disturbed, as evidenced by hyperkeratosis of the skin, 
erythrokeratoderma, and osteal plugging (Richard et al., 2002; van 
Steensel et al., 2002). Patients with the lethal Cx26-G45E mutation 
also suffer bacterial infections and succumb to septicemia within the 
first year of life (Janecke et al., 2005; Griffith et al., 2006; Jonard 
et al., 2008; Sbidian et al., 2010). To determine whether the induc-
ible Cx26-G45E transgenic mice developed epidermal pathology 
consistent with KIDS, we first analyzed neonatal mice that had been 
induced with doxycycline from conception. When the TRE-G45E 
transgene was induced in utero and expression was maintained 
postnatally, K14-rtTA plus TRE-G45E double-transgenic mice had a 
mortality rate exceeding 50% by weaning and surviving animals 
were generally in poor health (data not shown). In contrast, K14-rtTA 
plus TRE-G45E double-transgenic animals raised without doxycy-
cline exhibited normal postnatal development, reproductive capa-
bility, and lifespan. When the TRE-G45E transgene was first induced 
with doxycycline in adults (5 wk of age), K14-rtTA plus TRE-G45E 
double-transgenic mice developed skin abnormalities within 7–14 d 
of induction. These changes manifested with erythrokeratoderma 
and epidermal scaling (Figure 4C). When mice induced as adults 
were maintained for longer periods, the skin pathology progres-
sively worsened. After 10 wk of transgene expression, severe skin 
changes were evident, with an extensively thickened epidermis 
FIGuRE 3: Generation of doxycycline-inducible Cx26-G45E 
transgenic mice. In the diagram of the construct used for generation 
of doxycycline-inducible Cx26-G45E transgenic mice (A), the 
TRE-minCMV promoter drives transcription of an mRNA encoding 
Cx26-G45E followed by an IRES and the EGFP. Cx26-G45E animals 
were interbred with mice expressing the reverse tetracycline 
transactivator (rtTA) controlled by the keratin14 (K14) promoter to 
produce double-transgenic animals, which were genotyped by PCR of 
tail DNA (B, D) and analyzed for gene expression by RT-PCR of skin 
RNA (C, E). After doxycycline induction, K14-rtTA single-transgenic 
mice (animals 1 and 2) produced only rtTA transcripts in total 
epidermal RNA samples, whereas K14-rtTA plus TRE-G45E double-
transgenic animals made both rtTA and G45E transcripts (animals 3 
and 4).
FIGuRE 2: Cx26-G45E expression induces hemichannel currents. 
Untransfected N2A cells (A) and N2A cells transfected with wild-type 
Cx26 (B) had similar membrane currents when stepped to membrane 
potentials between −90 and +90 mV. N2A cells expressing Cx26-
G45E induced much larger whole-cell membrane currents at both 
hyperpolarizing and depolarizing potentials (C). A plot of current 
density vs. voltage (D) showed that Cx26-G45E currents were 
significantly larger than those recorded in either untransfected or 
wild-type Cx26 expressing cells at all tested voltages (p < 0.01, 
ANOVA). In addition to whole-cell membrane currents, single-channel 
activity was observed in Cx26-G45E–transfected cells with a unitary 
conductance value of ∼320 pS (E), consistent with the size expected 
for a Cx26 hemichannel.
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leading to scaling and deepened skin folds with a rough, coarse-
grained appearance (Figure 5). The skin phenotype and greatly re-
duced survival of induced K14-rtTA plus TRE-G45E double-trans-
genic mice is consistent with the disease seen in human KIDS 
patients with the G45E mutation.
Histological examination of adult head skin from control 
(Figure 6A) or K14-rtTA plus TRE-G45E double-transgenic mice 
induced for 4 wk (Figure 6B) showed a noticeably thickened epi-
dermis (acanthosis) and greater undulation of the epidermis into 
the dermis (papillomatosis) in Cx26-G45E animals compared with 
control littermates. The stratum corneum was thickened and com-
pact but orthokeratotic. The hair follicle epithelium was also acan-
thotic and hyperkeratotic, leading to horny cysts and follicular 
plugging. Keratinocytes appeared large, and there was also an in-
creased number of mitotic epidermal cells in Cx26-G45E animals 
compared with the control littermates, suggesting possible hyper-
proliferation. The subepidermal dermis showed elongated and 
dilated capillaries and a mild lymphocytic infiltration. Similar histo-
logical features were seen in skin samples taken from trunk, tail, or 
paw (data not shown). After 10 wk of transgene induction, the epi-
dermis displayed a massive hyperkeratosis with frequent keratotic 
plugging and extensive hair follicle and sebaceous gland atrophy 
(Figure 6C). These histological findings are consistent with the epi-
dermal pathology seen in human KIDS patients, especially those 
manifesting the lethal form of the disease (Sbidian et al., 2010; 
Koppelhus et al., 2011). Thus K14-rtTA plus TRE-G45E double-
transgenic mice offer a promising model for studies of epidermal 
pathology that arise from Cx26 mutations linked to the lethal form 
of KIDS.
Increased apoptosis and mitosis in Cx26-G45E 
transgenic mice
Epidermal thickness is maintained by a balance between cell pro-
liferation in the basal layer and cell shedding in the cornified layer. 
To gain insight into how this balance is perturbed in the skin of 
K14-rtTA plus TRE-G45E double-transgenic mice, we examined 
apoptosis and cell proliferation by staining frozen sections from 
control and Cx26-G45E animals with antibodies to either cleaved 
caspase-3 or phospho-histone-3. Staining for the apoptotic marker 
cleaved caspase-3 was absent in both the dermal and epidermal 
layers of adult control head skin (Figure 7A). In sections of head 
skin from K14-rtTA plus TRE-G45E double-transgenic mice that 
had been induced with doxycycline for 3 wk, a substantial increase 
in cleaved caspase-3 staining was observed, particularly in the der-
mis, in the thickened hair follicle epithelium, and possibly within 
gland structures (Figure 7B). Adult control head skin did show 
sparse staining of the mitotic marker phospho-histone-3 primarily 
in the epidermal layer, with additional staining in follicular and 
glandular structures of the dermis (Figure 7C). In K14-rtTA plus 
TRE-G45E double-transgenic mice that had been induced for 
3 wk, phospho-histone-3 staining was markedly increased in the 
thickened epidermal layer (Figure 7D). These data suggest that 
FIGuRE 4: Transgenic expression of Cx26-G45E in mouse epidermis. 
Frozen sections of head epidermis from the single K14-rtTA 
transgenic animals (A) showed no EGFP (green) or Cx26 expression 
(red). K14-rtTA plus TRE-G45E double-transgenic mice showed a large 
induction of EGFP in keratinocytes and a punctate pattern of 
Cx26-G45E staining (B). Whole-animal imaging of double transgenic 
mice (C, right) after 2 wk of doxycycline induction demonstrated skin 
abnormalities, including erythrokeratoderma and epidermal scaling 
that was not seen in single transgenic control animals (C, left). Skin 
abnormalities correlated with activation of the TRE-G45E transgene, 
which was monitored by EGFP fluorescence in living animals (D, right). 
Scale bar, A and B, 15 μm.
FIGuRE 5: Cx26-G45E transgenic mice develop skin abnormalities. 
Animals were maintained on doxycycline for 10 wk after initial 
induction at 5 wk of age. K14-rtTA plus TRE-G45E double-transgenic 
mice showed severely altered skin compared with single-transgenic 
control littermates (A). Higher-power views of the head revealed an 
extensively thickened epidermis with deepened skin folds and a 
coarse-grained appearance in the double-transgenic mouse (B, D) 
compared with the normal adult skin of the control mouse (C, E). The 
major units of the ruler in A are centimeters.
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both cell division and cell death signaling pathways are modulated 
in the diseased skin of Cx26-G45E animals, although in different 
locations, with increased apoptosis occurring primarily in the der-
mis and cell proliferation being increased in the epidermis.
Transgenic Cx26-G45E keratinocytes display increased 
hemichannel activity
Transgenic expression of Cx26-G45E in the epidermis recapitulated 
the histopathology seen in human KIDS patients. If the aberrant he-
michannel activity shown by this mutation in vitro contributed to 
epidermal pathology observed in vivo, then primary keratinocytes 
isolated from transgenic skin should also display increased hemi-
channel activity when compared with control keratinocytes. To test 
this hypothesis, we isolated keratinocytes from control or K14-rtTA 
plus TRE-G45E double-transgenic mice and measured whole-cell 
membrane currents and single-channel conductance by patch clamp 
electrophysiology. Neonatal K14-rtTA plus TRE-G45E double-trans-
genic mice (P2) that had been induced with doxycycline in utero 
were easily distinguished from their control littermates by their re-
duced size, reddish appearance (Figure 8A), and uniform epidermal 
expression of EGFP (Figure 8B). Isolated Cx26-G45E keratinocytes 
retained EGFP expression (Figure 8C), facilitating their identification 
for whole-cell patch clamp analysis. Keratinocytes isolated from con-
trol mice displayed modest membrane currents when stepped to 
membrane potentials between −90 and +90 mV (Figure 8D). In con-
trast, Cx26-G45E keratinocytes exhibited significantly increased 
whole-cell membrane currents at both hyperpolarizing and depolar-
izing membrane potentials (Figure 8E). Plotting the current density 
as a function of membrane potential (Figure 8F) showed that K14-
rtTA plus TRE-G45E double-transgenic currents were greater than 
fivefold larger (p < 0.01, Student’s t test) than those recorded in 
control keratinocytes. In some primary K14-
rtTA plus TRE-G45E double-transgenic cells, 
the activity of single Cx26-G45E hemichan-
nels could be resolved (Figure 8G). In the 
example shown, the hemichannels had a 
unitary conductance value of ∼315 pS at a 
membrane potential of −30 mV measured in 
120 mM K+ aspartate−, a value in excellent 
agreement with the Cx26-G45E hemichan-
nel conductance recorded in transfected 
N2A cells (Figure 2E). No single channels of 
this size were observed in control keratino-
cytes. Thus the increased hemichannel ac-
tivity seen for Cx26-G45E in exogenous ex-
pression systems persists in primary isolated 
keratinocytes from K14-rtTA plus TRE-G45E 
double-transgenic mice.
Cx26-G45E keratinocytes have a 
significantly increased cell size
In human patients carrying the lethal Cx26-
G45E mutation, histological examination of 
skin biopsies suggested that keratinocytes 
in the epidermis were swollen (Sbidian et 
al., 2010). To determine whether our trans-
genic mice replicated this aspect of KIDS 
pathology, we measured keratinocyte cir-
cumference in histological sections and 
freshly isolated keratinocyte cell membrane 
capacitance (a measure of cell surface area) 
by patch clamp. Skin sections from control 
(Figure 9A) or K14-rtTA plus TRE-G45E double-transgenic (Figure 
9B) animals that were stained with rhodamine-conjugated wheat 
germ agglutinin showed clearly demarcated keratinocyte cell bor-
ders. Cell perimeters from control (Figure 9, C and D) and Cx26-
G45E (Figure 9, E and F) mice were traced across the entire epider-
mal layer using cellSens imaging software and normalized to the 
average perimeter value for control keratinocytes. K14-rtTA plus 
TRE-G45E double-transgenic mice had a 28% increase in cell perim-
eter (p < 0.01, Student’s t test) compared with littermate controls 
(Figure 9G). This finding was confirmed by capacitance measure-
ments made from postnatal day 2 (P2) Cx26-G45E mice that had 
been induced with doxycycline in utero and 10-wk-old Cx26-G45E 
mice (P70) that had been induced with doxycycline for 5 wk (Figure 
9H). There was no significant difference between the membrane ca-
pacitance of control keratinocytes measured at P2 and P70 (p = 
0.34). In contrast, membrane capacitance was increased 51% (p < 
0.01) in P2 and 74% (p < 0.01) in P70 K14-rtTA plus TRE-G45E dou-
ble-transgenic keratinocytes. These data show that when measured 
by two independent methods, keratinocytes from Cx26-G45E trans-
genic mice were significantly larger than their littermate controls 
and that cell size increased with disease progression.
DISCUSSION
We generated an animal model replicating the skin pathology of 
the lethal form of KIDS by inducible transgenic expression of the hu-
man Cx26-G45E mutation in mouse keratinocytes. Cx26-G45E mice 
displayed most major features of the human disease, including greatly 
reduced viability, hyperkeratosis, acanthosis, papillomatosis, and ex-
tensive ichthyosiform scaling. Transgenic Cx26-G45E keratinocytes 
also showed significantly increased whole-cell capacitance compared 
with controls, features consistent with histological observations of 
FIGuRE 6: Histological analysis of Cx26-G45E transgenic skin. Adult head skin samples from 
control animals (A) displayed normal epidermal and dermal morphology after 4 wk of 
doxycycline application. In contrast, K14-rtTA plus TRE-G45E double-transgenic mice (B) induced 
for 4 wk demonstrated massive skin hyperplasia with greatly increased thickening of the 
epidermis (acanthosis), papillomatosis (undulation of the epidermis into the dermis), and a 
thickened, compact stratum corneum (hyperkeratosis). Animals maintained on doxycycline for 
10 wk had pronounced hyperkeratosis with frequent keratotic plugging and sebaceous gland 
atrophy (C). A and B were photographed with a 20× objective (scale bar, 50 μm), and C was 
photographed with a 4× objective (scale bar, 100 μm).
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increased cell size in skin biopsies from human KIDS patients. These 
skin changes were correlated with a significant increase in whole-cell 
membrane hemichannel currents detected in freshly isolated primary 
keratinocytes that were biophysically indis-
tinguishable from those measured following 
inducible expression of Cx26-G45E in tissue 
culture cells. These results confirm the patho-
genic nature of the Cx26-G45E mutation and 
provide a new model for future studies of the 
effects of aberrant connexin hemichannels in 
human connexin disorders of epithelial dif-
ferentiation and cornification.
There are two other transgenic models of 
skin disease caused by human Cx26 muta-
tions that can be compared with the Cx26-
G45E mice. Expression of Cx26-D66H in su-
prabasal keratinocytes under the control of 
the keratin 10 promoter mimicked many fea-
tures of Vohwinkel syndrome (VS) seen in hu-
man patients carrying this mutation (Bakirtzis 
et al., 2003). Instead of localizing at intercel-
lular gap junctions, the transgenic Cx26-
D66H accumulated within the keratinocyte 
cytoplasm, indicating abnormal trafficking of 
mutant Cx26. Consistent with in vitro data 
demonstrating a trans-dominant effect of 
mutant Cx26 on other coexpressed wild-type 
connexins (Rouan et al., 2001), Cx30 was also 
trapped into the cytoplasm of keratinocytes 
in Cx26-D66H transgenic mice. Early postna-
tal animals showed epidermal scaling with 
zonal hyperkeratosis of the tail and digits 
producing constriction bands, a hallmark 
feature of VS. Microscopic analysis revealed 
areas of hyperkeratosis and a thickened stra-
tum corneum associated with an increase in 
keratinocyte apoptosis, as well as increased 
proliferation in the lesional areas. These re-
sults were consistent with the skin pathology 
seen in human patients (Maestrini et al., 
1999) and suggested that the D66H muta-
tion caused premature keratinocyte death in 
the upper epidermis, with compensatory hy-
perproliferation in the basal layer, leading to 
a thickened stratum corneum. Although 
Cx26-G45E mice also showed increased epi-
dermal cell proliferation, our assay showed 
only increased apoptosis in the dermis, local-
izing mainly to hair follicles and possibly 
sweat glands, which may be related to the 
atrophy of these structures in transgenic skin 
and human patients.
In a recently developed model of KIDS, a 
conditional mouse mutant was generated to 
express the Cx26-S17F mutation under con-
trol of the endogenous murine Cx26 pro-
moter after deletion of the floxed wild-type 
Cx26 coding region (Schutz et al., 2011). 
Breeding this line with a phosphoglycerate 
kinase Cre-expressing strain produced a 
ubiquitous knock-in of the human Cx26-
S17F allele in the native mouse Cx26 locus. 
Homozygous mutant animals were not viable, which could be pre-
dicted by the complete lack of any channel function by Cx26-S17F 
in vitro (Richard et al., 2002; Lee et al., 2009) and the fact that 
FIGuRE 7: Altered apoptosis and mitosis in Cx26-G45E transgenic skin. Cell death and 
proliferation were determined by immunofluorescence staining using antibodies against either 
cleaved caspase-3 or phospho-histone-3, respectively. Frozen sections of head skin from adult 
control animals (A, blue DAPI stain) showed no staining for the apoptotic marker cleaved 
caspase-3 (red) in either the dermal or epidermal layers. There was a substantial increase in 
cleaved caspase-3 staining, especially in the dermis of the double-transgenic animals (B, green 
EGFP) after 3 wk of induction by doxycycline. Inset, stained cells in thickened hair follicle 
epithelium. For the proliferation-specific marker phospho-histone-3, adult control head skin 
(C) had sparse staining (red) primarily in the epidermal layer, as well as in follicular and glandular 
structures of the dermis. In Cx26-G45E transgenic mice induced with doxycycline for 3 wk (D), 
an increase in phospho-histone-3 staining was observed in the thickened epidermal layer (inset). 
Scale bar, 50 μm.
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homozygous knockout Cx26 mice are embryonic lethal (Gabriel 
et al., 1998). Surviving heterozygous mice displayed hyperplasia of 
the tail and foot epidermis and annular tail restrictions, a milder 
epidermal phenotype than shown by the Cx26-G45E animals, which 
is consistent with a milder epidermal disease in humans carrying 
Cx26-S17F (Richard et al., 2002; Mazereeuw-Hautier et al., 2007). 
Unlike the majority of other KIDS mutations, Cx26-S17F fails to form 
hemichannels in vitro (Lee et al., 2009), and this may partially ex-
plain the milder phenotype in humans and transgenic mice. The 
authors also reported that the total number of heterozygous Cx26-
S17F mice born was much lower than that given by the expected 
Mendelian ratio. This was surprising, as human Cx26-S17F patients 
have not been reported to have the infant mortality associated with 
Cx26-G45E (Janecke et al., 2005; Jonard et al., 2008; Sbidian et al., 
2010). The increase in mouse mortality may have been due to differ-
ences in the expression pattern of Cx26 in human and murine epi-
dermis. In human skin, Cx26 is found in a patchy distribution in 
basal keratinocytes but is more highly expressed in palmer and 
plantar epidermis, eccrine sweat glands, hair follicles, and all epi-
dermal layers after injury or in hyperproliferative disease (Richard, 
2001). In mice, Cx26 is present in the upper suprabasal/granular 
layers of the epidermis in tail skin (Schutz et al., 2011). Further com-
parison between these animal models may be helpful in character-
izing the extensive phenotypic overlap among different skin disease 
FIGuRE 8: Increased hemichannel activity in transgenic Cx26-G45E 
keratinocytes. Whole-cell membrane currents and hemichannel 
activities of the primary keratinocytes isolated from neonatal control 
and K14-rtTA plus TRE-G45E double-transgenic mice induced with 
doxycycline in utero were measured by patch clamp 
electrophysiology. Neonatal double-transgenic mice were smaller 
than the control littermates and had a red, shiny appearance (A), 
which was correlated with transgene activation as seen by whole-
animal EGFP fluorescence (B). Keratinocytes isolated from K14-rtTA 
plus TRE-G45E double-transgenic mice retained EGFP expression (C, 
scale bar, 5 μm). Keratinocytes isolated from control animals displayed 
modest whole-cell membrane currents (D) when stepped to 
membrane potentials between −90 and +90 mV. In contrast, 
Cx26-G45E keratinocytes exhibited significantly increased membrane 
currents (E) compared with controls. Plotting the current density as a 
function of membrane potential (F) quantified greater than fivefold 
increase (p < 0.01, Student’s t test) in membrane currents recorded 
from K14-rtTA plus TRE-G45E double-transgenic keratinocytes. When 
the single-channel activity of the Cx26-G45E hemichannels was 
detected, the unitary conductance was observed to be ∼315 (G), 
comparable to that of Cx26-G45E hemichannels recorded from 
transfected N2A cells (Figure 2).
FIGuRE 9: Transgenic Cx26-G45E keratinocytes are larger. 
Keratinocyte size was compared between double-transgenic mice and 
the control animals by two independent methods. Cell perimeters in 
sections of control (A) and K14-rtTA plus TRE-G45E double-transgenic 
skin (B) were labeled with rhodamine-conjugated wheat germ 
agglutinin. Cell perimeters were measured in control (C, D) and 
Cx26-G45E sections (E, F) using the tracing function of cellSens 
imaging software. Quantification of these data showed that double-
transgenic animals had a 28% increase in keratinocyte perimeter 
compared with control mice (G; p < 0.01, Student’s t test). 
Measurement of membrane capacitance from isolated primary 
keratinocytes by whole-cell patch clamp (H) showed 51% (p < 0.01) 
and 74% (p < 0.01) increases in cell capacitance in K14-rtTA plus 
TRE-G45E double-transgenic keratinocytes compared with control 
cells on postnatal days 2 and 70, respectively. Scale bar, 15 μm.
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syndromes associated with connexin mutations (van Steensel et al., 
2004).
The vast majority of Cx26 mutations linked to KIDS have been 
shown to display increased hemichannel activity (Montgomery et al., 
2004; Stong et al., 2006; Gerido et al., 2007; Lee et al., 2009; Sanchez 
et al., 2010; Terrinoni et al., 2010). Biophysical studies of Cx26-A40V 
and Cx26-G45E hemichannels found that both showed impaired 
regulation by extracellular Ca2+, increasing the likelihood of aberrant 
hemichannel opening. Cx26-G45E hemichannels specifically exhib-
ited a substantial increase in permeability to Ca2+ ions compared 
with wild-type Cx26, providing a route for excessive entry of Ca2+ 
into keratinocytes in epidermal tissue (Sanchez et al., 2010). Ex-
tracellular calcium plays important roles in normal epidermal dif-
ferentiation, regulating cell proliferation, terminal differentiation, 
and cell-to-cell adhesion, as well as being implicated in the 
pathogenesis of some types of skin disease (Hennings et al., 
1980; Fairley, 1991; Bikle et al., 2004; Tu et al., 2004). Changes 
in the extracellular Ca2+ concentration are believed to help drive 
a developmental switch from keratinocyte proliferation to termi-
nal differentiation by providing an extracellular reservoir of Ca2+ 
ions to influence intracellular calcium-dependent signaling pro-
cesses. In the case of the Cx26-G45E mutation, the combined 
effects of increased hemichannel activity and increased hemi-
channel Ca2+ permeability would be expected to wreak havoc on 
the delicate balance between keratinocyte proliferation and dif-
ferentiation mechanisms. The availability of a mouse model that 
faithfully recapitulates Cx26-G45E–induced skin disease will fa-
cilitate future studies to further explore the relationship between 
increased hemichannel activity and epidermal homeostasis, with 
the ultimate goal of developing new therapies to treat this lethal 
human disorder.
MATERIALS AND METHODS
Molecular cloning
pIRES2-EGFP (Clontech Laboratories, Mountain View, CA) was di-
gested with SacII and NotI to liberate the IRES2-EGFP cassette, 
which was then subcloned into the SacII-NotI sites of pTRE2 (Clon-
tech Laboratories). The Cx26-G45E cDNA was then subcloned into 
BamHI site of the pTRE2-IRES2-EGFP construct in order to generate 
the plasmid pTRE2-Cx26-G45E-IRES2-EGFP. This construct was used 
for cotransfection of intercellular communication–deficient neuro-2A 
(N2A) or HeLa cells together with the pTet-On vector (Clontech 
Laboratories) for immunocytochemical, dye uptake, and patch clamp 
studies. The construct was also digested with AatII and DrdI to ob-
tain a ∼4-kb linear transgene free of plasmid sequences (abbreviated 
TRE-G45E) for zygotic pronuclear injection to generate transgenic 
mice.
Cell transfection
N2A or HeLa cells were transiently cotransfected either with a 1:5 
mixture of pTet-On vector (1 μg) and pTRE2-Cx26-G45E-IRES2-
EGFP (5 μg) or with a 1:5 mixture of pTet-On vector and pTRE2-
Cx26-IRES2-EGFP using Lipofectamine 2000 reagent (Invitrogen, 
Carlsbad, CA) following the manufacturer’s protocol. Briefly, 1 d 
before transfection, cells were plated so that they would be 70–
95% confluent on the day of transfection. Lipofectamine 2000 
reagent, plasmids, and OPTI-MEM medium (Invitrogen) were 
brought to room temperature. DNA (total of 6 μg) and Lipo-
fectamine 2000 (6 μl) were individually diluted in OPTI-MEM. Fol-
lowing 20 min of incubation at 37°C, the DNA and Lipofectamine 
mixture was added onto the cells drop by drop, and cells were 
incubated at 37°C for 18–24 h. The following day, the medium 
was changed to regular medium supplemented with a final con-
centration of 1 μg/μl doxycycline (Sigma-Aldrich, St. Louis, MO) 
and 2 mM CaCl2, and cells were incubated for an additional 24 h 
to allow the induction of gene expression. Cells were then used 
for immunofluorescence staining, patch clamp electrophysiol-
ogy, or dye uptake assays.
Immunocytochemistry
Transiently transfected HeLa cells were fixed with 1% paraformalde-
hyde in phosphate-buffered saline (PBS), blocked, and permeabi-
lized with 5% bovine serum albumin (BSA) in PBS with 0.1% Triton 
X-100. Cells were stained with a polyclonal rabbit anti-Cx26 (Zymed, 
San Francisco, CA), washed with 0.1% Triton X-100/PBS, incubated 
with a Cy3-conjugated anti-rabbit secondary antibody (Jackson 
ImmunoResearch Laboratories, West Grove, PA), washed with 
0.1% Triton X-100/PBS, and mounted on slides using Vectashield 
with 4′,6-diamidino-2-phenylindole (DAPI) (Vector Laboratories, 
Burlingame, CA). Skin samples comprising the epidermis and der-
mis were dissected and fixed in a 1% formaldehyde solution in PBS 
for 1 h at room temperature. Fixed tissues were rinsed with PBS, 
immersed in Optimal Cutting Temperature compound (OCT; Ted 
Pella, Redding, CA), and frozen. Sections of thickness 8–10 μm were 
cut on a cryotome, dried onto glass slides, and stained with poly-
clonal rabbit antibodies against Cx26 (Zymed), phospho-histone-3 
(Cell Signaling Technology, Danvers, MA), or cleaved caspase-3 
(Cell Signaling Technology), washed with 0.1% Triton X-100/PBS, 
incubated with Cy3-conjugated anti-rabbit secondary antibodies, 
washed with 0.1% Triton X-100/PBS, and mounted on slides using 
Vectashield with DAPI. Stained slides were viewed on a BX51 micro-
scope and photographed with a DP72 digital camera (Olympus, 
Lake Success, NY).
Neurobiotin uptake assay
Neurobiotin (Vector Laboratories) was dissolved at 0.1 mg/ml in PBS 
without calcium. Cells grown on coverslips were first washed with 
calcium-free medium for 20 min, followed by incubation in neuro-
biotin solution for 20 min at 37°C. Cells were then washed three 
times with PBS supplemented with 2 mM CaCl2 for 10 min at 37°C 
and fixed with 1% paraformaldehyde in PBS for 30 min at room 
temperature. After fixation, cells were washed three times with PBS 
for 5 min, permeabilized with 0.1% Triton X-100/PBS for 20 min, and 
blocked with 3% BSA/0.1% Triton X-100/PBS for 1 h at room tem-
perature. Cells were then incubated with 1:1000 dilution of tetra-
methylrhodamine isothiocyanate–conjugated avidin in 3% BSA/0.1% 
TritonX-100/PBS (Vector Laboratories) for 1 h at room temperature 
in the dark, washed three times for 10 min with 0.1% Triton X-100/
PBS, and mounted on slides using Vectashield with DAPI. Images 
were acquired at the same exposure time for all conditions with a 
DP72 digital camera on a BX51 microscope (Olympus).
Patch clamp electrophysiology
Experiments were carried out on transiently transfected N2A cells or 
primary isolated mouse keratinocytes at room temperature. Cells 
transfected with wild-type Cx26 or the G45E mutation were grown 
in medium supplemented with 2 mM CaCl2 until the measurements 
were performed. Cells on glass coverslips were transferred to the 
experimental chamber with a bath solution containing (in mM) 137.7 
NaCl, 5.4 KCl, 2.3 NaOH, 1 MgCl2, 2 CsCl2, 4 BaCl2 10 glucose, 
and 5 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) 
(pH 7.4), where CaCl2 was omitted from the bath solution. Patch 
pipettes were pulled from glass capillaries with a horizontal puller 
(Sutter Instruments, Novato, CA) and filled with a pipette solution of 
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120 mmol/l K aspartate, 5 mM HEPES, 10 mM ethylene glycol tet-
raacetic acid, and 3 mM NaATP (pH 7.2). Single cells were selected 
and used to measure the membrane capacitance, as well as the 
membrane currents (Im) invoked while the membrane potential (Vm) 
was stepped from −90 to +90 mV in 20-mV increments.
Generation of transgenic mice
All animal work was done with approval of the Stony Brook Univer-
sity Institutional Animal Care and Use Committee. TRE-G45E trans-
genic mice were generated by zygotic pronuclear injection followed 
by embryo transfer into pseudopregnant female animals. Positive 
founder mice were interbred with a second transgenic strain (Nguyen 
et al., 2006) expressing the reverse tetracycline transactivator under 
the control of the keratin14 (abbreviated K14-rtTA) promoter to pro-
duce doubly transgenic animals. Transgenic mice were identified by 
amplification of tail genomic DNA using the PCR Extender System 
(5 PRIME, Gaithersburg, MD). The TRE-G45E transgene was de-
tected using the primer pair 5′-CATTGTCATGTACGACGGCT-
TCTC-3′ and 5′-GGTACCTTCTGGGCATCCTT-3′. The K14-rtTA 
transgene was detected using the primer pair 5′-CACGATACAC-
CTGACTAGCTGGGTG-3′ and 5′-CATCACCCACAGGCTAGCGC-
CAACT-3′. PCR products were run on 2% agarose gels, visualized 
with ethidium bromide, and photographed. Transgenic animals 
were backcrossed to the SKH1 hairless mouse strain (Charles River, 
Wilmington, MA) to facilitate visual observation of the epidermis. 
For in vivo fluorescence detection of EGFP expression, mice were 
anesthetized with isoflurane and imaged using a Maestro small-ani-
mal imaging system (CRi, Woburn, MA).
RT-PCR analysis
Total mRNA was prepared from mouse skin samples using the 
RNeasy Kit (Qiagen, Germantown, MD) following the manufacturer’s 
protocol. RNA samples were treated with DNase I for 30 min, ex-
tracted with phenol/chloroform, ethanol precipitated, and resus-
pended in diethylpyrocarbonate-treated water. cDNAs were synthe-
sized using the SuperScript III First-Strand Synthesis System for 
RT-PCR (Invitrogen) following the manufacturer’s protocol using ran-
dom hexamer primers. cDNAs were used as templates in PCRs to 
amplify the TRE-G45E transgenic transcript using the primer pair 
5′-GACTGTCTTCACAGTGTTCATGATT-3′ and 5′-TGTATCTTATA-
CACGTGGCTTTTGG-3′ or the K14-rtTA transgenic transcript using 
the primer pair 5′-ACTGGACAAGAGCAAAGTCATAAAC-3′ and 
5′-CTCTTTCCTCTTTTGCTACTTGATG-3′. PCR products were run 
on a 2% agarose gel, visualized with ethidium bromide, and photo-
graphed.
Histology
Skin samples comprising the epidermis and dermis were dissected 
and fixed in a 4% formaldehyde solution in PBS for 16–24 h at room 
temperature. Fixed tissues were rinsed with PBS, dehydrated 
through an ethanol series, and embedded in paraffin. Sections of 
thickness 2–3 μm were cut on a diamond knife, deparaffinized, and 
stained with hematoxylin–eosin. Some sections were deparaffinized, 
rehydrated, blocked with 3% BSA/0.1% Triton X-100/PBS for 1 h at 
room temperature, and stained with rhodamine-conjugated wheat 
germ agglutinin in 3% BSA/0.1% Triton X-100/PBS (Vector Labora-
tories) for 1 h at room temperature in the dark, washed three times 
for 10 min with 0.1% Triton X-100/PBS, and mounted on slides using 
Vectashield with DAPI. Sections were viewed on a BX51 microscope 
and photographed with a DP72 digital camera. Cell perimeters 
were traced and measured using cellSens digital imaging software 
(Olympus).
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